STEMNESS

作品数：160被引量：402H指数：9
导出分析报告
相关领域：医药卫生生物学更多>>
相关作者：张厦陈策实周凯旋林勇魏金旺更多>>
相关机构：匹兹堡大学空军军医大学（第四军医大学）大连医科大学北京大学肿瘤医院更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划中国博士后科学基金福建省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Prognostic significance and multidimensional roles of interferon regulatory factors in cancer biology:A comprehensive analysis
《Genes & Diseases》2025年第3期15-18,共4页Guo Ji Shuyuan Xian Jiaqi Song Shiyu Mao Man Pi Qiongyi Huang Xue Han Jian Yin Zan Wu Runzhi Huang Dongyan Han Zhengyan Chang 
supported in part by the National Natural Science Foundation of China(No.82002923,82203505).
Interferon regulatory factors(IRFs)are transcription factors with a conserved N-terminal helix-loop-helix DNA-binding domain 1.IRF family plays a pivotal role in regulating interferon transcription,immune cell develop...
关键词：interferon regulatory factors irfs interferon regulatory factors multidimensional correlation analysiswe multidimensional roles STEMNESS transcription factors immune subtype cancer biology 
Phospholipid Metabolism Reprogramming of Cancer Stem Cells and Its Impacts on Stemness
《BIOCELL》2025年第4期579-605,共27页Qing Wang Luyao Cai Shouyi Tang Dan Pan Zhen Wang Qianming Chen Yu Zhou Yingqiang Shen 
supported by grants from National Natural Science Foundation of China(81902784,81771086);by the Fund of Sichuan Provincial Department of science and technology(2024YFFK0393,2022YFS0039);the Research and Develop Program,West China Hospital of Stomatology,Sichuan University(LCYJ2023-DL-2,RD-02-202002);the CAMS Innovation Fund for Medical Sciences(CIFMS,2019-I2M-5-004)。
Cancer Stem Cells(CSCs)are cancer cells with self-renewal and tumorigenesis abilities.CSCs in tumor tissues are the leading cause of tumor progression,recurrence,and drug resistance.CSCs have distinct metabolic featur...
关键词：Neoplastic stem cells cancer stem cells PHOSPHOLIPIDS phosphatides METABOLISM 
Role of octamer transcription factor 4 in proliferation,migration,drug sensitivity,and stemness maintenance of pancreatic cancer cells
《World Journal of Clinical Oncology》2025年第3期83-94,共12页Xue-Ying Shi Xi-Lan Wang Jin Zhao Shi-Hai Yang Cheng-Hai Zhang 
Supported by Inner Mongolia Natural Science Foundation and the 3rd Affiliated of Inner Medical University,No.2021MS08067.
BACKGROUND Pancreatic cancer(PC)is one of the most aggressive malignancies characterized by rapid progression and poor prognosis.The involvement of cancer stem cells(CSCs)and Octamer transcription factor 4(OCT4)in PC ...
关键词：Pancreatic cancer Octamer transcription factor 4 Cancer stem cells PROLIFERATION Drug sensitivity STEMNESS 
Targeting STAT3 with SH-4-54 suppresses stemness and chemoresistance in cancer stem-like cells derived from colorectal cancer
《World Journal of Clinical Oncology》2025年第2期63-75,共13页Xu-Fan Zhang Qian Chen Qin Jiang Qiong-Ying Hu 
BACKGROUND Over the years,the numbers of treatment options for colorectal cancer(CRC)have increased,leading to notable improvements in the overall survival of CRC patients.Although therapy may initially yield positive...
关键词：SH-4-54 Colorectal cancer Cancer stem-like cells STEMNESS CHEMOSENSITIVITY 
Cascade specific endogenous Fe^(3+)interference and in situ catalysis for tumor therapy with stemness suppression
《National Science Review》2025年第2期253-269,共17页Jiajie Chen Yitong Wang Jian Huang Zhibo Yang Huicong Niu Xiaolian Su Jimin Huang Hongshi Ma Yufang Zhu Chengtie Wu Jianlin Shi 
supported by the National Key Research and De-velopment Program of China(2022YFB3804500);the Shanghai Pilot Program for Basic Research-Chinese Academy of Sciences,Shanghai Branch(JCYJ-SHFY-2022-003);the National Natu-ral Science Foundation of China(22335006 and 32101090);the China Postdoctoral Science Foundation(2024M763409);the Shanghai Rising-Star Project(Sailing Program)(24YF2753400);the Key Research Program of Frontier Sciences,Chinese Academy of Sciences(ZDBS-LY-SLH029).
Cancer stem-li ke cel ls(CSCs),featuring high tumorigenicity and invasiveness,are one of the critical factors leading to the failure of clinical cancer treatment such as metastasis and recurrence.However,current strat...
关键词：cancer stem-likecells stemness inhibition NANOMEDICINE endogenous Fe^(3+)interference catalytic therapy 
Chronic exposure to hexavalent chromium induces esophageal tumorigenesis via activating the Notch signaling pathway
《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》2025年第1期76-91,共16页Yilin ZHU Fanrong LIU Lei LIU Jinfu WANG Fengyuan GAO Lan YE Honglei WU Chengjun ZHOU Guimei LIN Xiaogang ZHAO Peichao LI 
supported by the Special Construction Project Fund for Taishan Mountain Scholars of Shandong Province;the Jinan Medicine Research Program;the Nurturing and Development Fund from The Second Hospital of Shandong University(No.2022YP62);the Shandong Provincial Natural Science Foundation for Young Scholars(No.ZR2022QH285),China.
Hexavalent chromium Cr(Ⅵ),as a well-established carcinogen,contributes to tumorigenesis for many human cancers,especially respiratory and digestive tumors.However,the potential function and relevant mechanism of Cr(...
关键词：Hexavalent chromium Cr(Ⅵ) Esophageal tumorigenesis Malignant proliferation STEMNESS Notch signaling pathway 
Post-fast refeeding:rise of intestinal stemness and mutageninduced cancer risk through polyamine metabolism
《Signal Transduction and Targeted Therapy》2024年第12期5357-5358,共2页Sarah Brunner Klaus-Peter Janssen Josef Ecker 
support from the Deutsche Forschungsgemeinschaft(DFG,German Research Foundation)project no 395357507-SFB 1371.
An increased intestinal stem cell activity following post fastrefeeding is beneficial for regeneration,but too much could increase the risk for cancer in mice,as reported in a recent study by Imada and colleagues publ...
关键词：metabolism cancer DIETARY 
N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression
《World Journal of Gastroenterology》2024年第48期5174-5190,共17页Yong Yu Xiang-Hong Lu Jin-Song Mu Jiang-Yun Meng Jiang-Shan Sun Hai-Xu Chen Yang Yan Ke Meng 
Supported by the National Natural Science Foundation of China,No.82271628.
BACKGROUND Hepatocellular carcinoma(HCC)is a prevalent and aggressive tumor.Sorafenib is the first-line treatment for patients with advanced HCC,but resistance to sorafenib has become a significant challenge in this t...
关键词：Hepatocellular carcinoma STEMNESS Sorafenib resistance Long non-coding RNA KIF9-AS1 Short stature homeobox 2 
Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling被引量：1
《Genes & Diseases》2024年第5期470-483,共14页Zhirong Zhang Jiayao Yang Rui Liu Jing Ma Kai Wang Xiaojun Wang Ni Tang 
the National Key Research and Development Program of China(No.2023YFC2306803);the China National Natural Science Foundation(No.82273238,82272975,82072286);the Innovative and Entrepreneurial Team of Chongqing Talents Plan,Chongqing Medical Scientific Research Project(Joint Project of Chongqing Health Commission and Science and Technology Bureau;No.2023DBXM007);Senior Medical Talents Program of Chongqing for Young and Middle-aged,the Kuanren Talents and DengFeng program of the Second Affiliated Hospital of Chongqing Medical University(China),the Future Medical Youth Innovation Team of Chongqing Medical University(China)(No.W0036,W0101);the Postdoctoral Fellowship Program of China Postdoctoral Science Foundation(No.GZC20233349).
Cancer stem cells(CSCs)play a crucial role in tumor initiation,recurrence,metastasis,and drug resistance.However,the current understanding of CSCs in hepatocellular carcinoma(HCC)remains incomplete.Through a comprehen...
关键词：Cancer stem cells HEDGEHOG Hepatocellular carcinoma METASTASIS STATIN 
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma被引量：1
《Signal Transduction and Targeted Therapy》2024年第10期4614-4627,共14页Qiaonan Shan Lu Yin Qifan Zhan Jiongjie Yu Sheng Pan Jianyong Zhuo Wei Zhou Jiaqi Bao Lincheng Zhang Jiachen Hong Jianan Xiang Qingyang Que Kangchen Chen Shengjun Xu Jingrui Wang Yangbo Zhu Bin He Jingbang Wu Haiyang Xie Shusen Zheng Tingting Feng Sunbin Ling Xiao Xu 
National Key Research and Development Program of China(2022YFA1106800),National Natural Science Foundation of China(82203070,82200726,82200727,92159202 and 82273270);Project of Medical and Health Technology Program in Zhejiang Province(2024KY853).
Lenvatinib is a targeted drug used for first-line treatment of hepatocellular carcinoma(HCC).A deeper insight into the resistance mechanism of HCC against lenvatinib is urgently needed.In this study,we aimed to dissec...
关键词：USP22 HEPATOCELLULAR diagnosis 
全选清除导出
共16页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部